Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 PatientsFrancesca Minoia, Angelo Ravelli, Sergio Davì et al.|Arthritis & Rheumatology|2014Cited by 430
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyAlessandro Consolaro, Rita Consolini, Dirk Foell et al.|The Lancet Child & Adolescent Health|2019Cited by 214
The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases seriesIsabelle Koné‐Paut, Maryam Piram, Rolando Cimaz et al.|Autoimmunity Reviews|2018Cited by 129
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR projectFrancesco Baldo, Sevcan A. Bakkaloğlu, Remco Erkens et al.|Lara D. Veeken|2024Cited by 31
Current Transition Practice for Primary Immunodeficiencies and Autoinflammatory Diseases in Europe: a RITA-ERN SurveyMuskan Israni, L. Marques, Federica Barzaghi et al.|Journal of Clinical Immunology|2022Cited by 27